{"id":47855,"date":"2022-08-31T16:02:10","date_gmt":"2022-08-31T14:02:10","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/texas-original-advocates-to-expand-compassionate-use-program-to-include-chronic-pain\/"},"modified":"2022-08-31T16:02:10","modified_gmt":"2022-08-31T14:02:10","slug":"texas-original-advocates-to-expand-compassionate-use-program-to-include-chronic-pain","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/texas-original-advocates-to-expand-compassionate-use-program-to-include-chronic-pain\/","title":{"rendered":"Texas Original Advocates To Expand Compassionate Use Program To Include Chronic Pain"},"content":{"rendered":"
\n

\nTexas\u2019 leading medical cannabis provider is highlighting the medicine\u2019s efficacy in pain management therapies during Pain Awareness Month<\/i>\n<\/p>\n

AUSTIN, Texas–(BUSINESS WIRE)–As Pain Awareness Month begins, Texas Original<\/a> is calling on Texas\u2019 legislature to add chronic pain as a qualifying condition to the state\u2019s Compassionate Use Program (CUP)<\/a>.\n<\/p>\n

<\/a><\/p>\n

\nThe CUP\u2019s current list of qualifying conditions includes cancer, PTSD, epilepsy and hundreds of neurodegenerative diseases but excludes the many other patients who could benefit from the proven power of medical cannabis to treat chronic pain.\n<\/p>\n

\n\u201cHardly a week goes by without seeing a headline about the staggering amount of fentanyl crossing the border or increase in opioid overdose deaths. Texas has an undeniable opioid problem that won\u2019t be fixed until prescribing physicians are given more viable options for treating their patients,\u201d said Texas Original CEO Morris Denton. \u201cThe ability to effectively treat a patient shouldn\u2019t come with the risk of addiction, yet that\u2019s the harsh reality that doctors and their patients find themselves in every day in Texas. The overprescription of opioids is forcing thousands of Texans to find illicit means of satisfying their addictions once their prescriptions run out. We owe it to our fellow Texans to give them a better alternative. Chronic pain is one of the most prevalent and provable conditions that medical cannabis can positively impact. It\u2019s not a maybe. It\u2019s a certainty. The science is there, the proof is there, now we need the legislature to be there as well.\u201d\n<\/p>\n

\nMedical cannabis has proven more effective and safer for some patients than prescription drugs. According to a 2021 Harm Reduction Journal study<\/a>, 38.1% of the 2,841 patients surveyed reported the termination of all prescription drugs when substituting with cannabis. An additional 45.9% cited a substantial decrease in prescription drug use and 65.8% found cannabis much more effective than their prescription.\n<\/p>\n

\nIn Texas, opioids are one of the leading medications prescribed to treat pain, with 17.7 million prescriptions issued annually<\/a>\u2014equating to more than 63 prescriptions per 100 persons. In July 2022, an observational study<\/a> released by the Annals of Internal Medicine found that the most common patient-reported condition was chronic pain, accounting for 60.6% of cannabis patients.\n<\/p>\n

\n\u201cThere is an overwhelming body of research that supports prescribing medicinal cannabis to reduce chronic pain,\u201d said Dr. Matthew Brimberry, a board-certified physician, member of Texas Original\u2019s Medical Advisory Board and head of Texas Cannabis Clinic. \u201cIn the United States, the No. 1 reason patients seek medical cannabis is to augment their pain management treatment. Due to its successful track record, I strongly believe that the CUP should add chronic pain to the list of qualifying conditions.\u201d\n<\/p>\n

\nRecent polls from Baselice & Associates, Inc.<\/a> as well as The Dallas Morning News and the University of Texas at Tyler<\/a> have also revealed overwhelming bipartisan support for the legalization of medical cannabis. In particular, the Baselice & Associates, Inc. poll found that 72% of Republican primary voters in Texas favored allowing physicians to prescribe medical marijuana as an alternative to opioids for treating chronic pain patients.\n<\/p>\n

\n\u201cThe data is clear. Medical cannabis is a highly effective\u2014and widely supported\u2014method of pain management that has proven safer than current legal options in the market today,\u201d added Denton.\n<\/p>\n

\nPatients with a qualifying condition can obtain medical cannabis prescriptions through online clinics or local physicians registered with the Compassionate Use Registry of Texas. Texas Original\u2019s high-quality medical cannabis is available through the company\u2019s extensive distribution network. Find a list of statewide pickup sites and operating times on the Texas Original website here<\/a>. To learn whether you or a loved one qualifies for medical cannabis, visit www.texasoriginal.com\/patients<\/a>.\n<\/p>\n

\nAbout Texas Original<\/b>\n<\/p>\n

\nTexas Original is the leading licensed medical cannabis producer in Texas, working alongside physicians to provide the highest quality cannabis medicine to patients and families seeking relief across the state. As fellow Texans, we are dedicated to representing the integrity of this great state with our commitment to quality, consistency and purity in every product we produce. We remain committed to advancing safe, legal access to this powerful medicine. Texas Original is headquartered in Austin, with delivery throughout the entire state. For more information, visit www.texasoriginal.com<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nFor Media Inquiries Only:<\/b>
Callie Neatherlin
\n
media@texasoriginal.com<\/a>
512-439-9720\n<\/p>\n

\nFor Prescription Inquiries:<\/b>
512-614-0343\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Texas\u2019 leading medical cannabis provider is highlighting the medicine\u2019s efficacy in pain management therapies during Pain Awareness Month AUSTIN, Texas–(BUSINESS WIRE)–As Pain Awareness Month begins, Texas Original is calling on Texas\u2019 legislature to add chronic pain as a qualifying condition to the state\u2019s Compassionate Use Program (CUP). The CUP\u2019s current list of qualifying conditions includes … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-47855","6":"format-standard","7":"category-industry"},"yoast_head":"\nTexas Original Advocates To Expand Compassionate Use Program To Include Chronic Pain - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/texas-original-advocates-to-expand-compassionate-use-program-to-include-chronic-pain\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Texas Original Advocates To Expand Compassionate Use Program To Include Chronic Pain - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Texas\u2019 leading medical cannabis provider is highlighting the medicine\u2019s efficacy in pain management therapies during Pain Awareness Month AUSTIN, Texas–(BUSINESS WIRE)–As Pain Awareness Month begins, Texas Original is calling on Texas\u2019 legislature to add chronic pain as a qualifying condition to the state\u2019s Compassionate Use Program (CUP). The CUP\u2019s current list of qualifying conditions includes ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/texas-original-advocates-to-expand-compassionate-use-program-to-include-chronic-pain\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-08-31T14:02:10+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220831005134\/en\/1306679\/21\/Texas_Original_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/texas-original-advocates-to-expand-compassionate-use-program-to-include-chronic-pain\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/texas-original-advocates-to-expand-compassionate-use-program-to-include-chronic-pain\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Texas Original Advocates To Expand Compassionate Use Program To Include Chronic Pain\",\"datePublished\":\"2022-08-31T14:02:10+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/texas-original-advocates-to-expand-compassionate-use-program-to-include-chronic-pain\\\/\"},\"wordCount\":726,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/texas-original-advocates-to-expand-compassionate-use-program-to-include-chronic-pain\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220831005134\\\/en\\\/1306679\\\/21\\\/Texas_Original_Logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/texas-original-advocates-to-expand-compassionate-use-program-to-include-chronic-pain\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/texas-original-advocates-to-expand-compassionate-use-program-to-include-chronic-pain\\\/\",\"name\":\"Texas Original Advocates To Expand Compassionate Use Program To Include Chronic Pain - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/texas-original-advocates-to-expand-compassionate-use-program-to-include-chronic-pain\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/texas-original-advocates-to-expand-compassionate-use-program-to-include-chronic-pain\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220831005134\\\/en\\\/1306679\\\/21\\\/Texas_Original_Logo.jpg\",\"datePublished\":\"2022-08-31T14:02:10+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/texas-original-advocates-to-expand-compassionate-use-program-to-include-chronic-pain\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/texas-original-advocates-to-expand-compassionate-use-program-to-include-chronic-pain\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/texas-original-advocates-to-expand-compassionate-use-program-to-include-chronic-pain\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220831005134\\\/en\\\/1306679\\\/21\\\/Texas_Original_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220831005134\\\/en\\\/1306679\\\/21\\\/Texas_Original_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/texas-original-advocates-to-expand-compassionate-use-program-to-include-chronic-pain\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Texas Original Advocates To Expand Compassionate Use Program To Include Chronic Pain\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Texas Original Advocates To Expand Compassionate Use Program To Include Chronic Pain - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/texas-original-advocates-to-expand-compassionate-use-program-to-include-chronic-pain\/","og_locale":"en_US","og_type":"article","og_title":"Texas Original Advocates To Expand Compassionate Use Program To Include Chronic Pain - Pharma Trend","og_description":"Texas\u2019 leading medical cannabis provider is highlighting the medicine\u2019s efficacy in pain management therapies during Pain Awareness Month AUSTIN, Texas–(BUSINESS WIRE)–As Pain Awareness Month begins, Texas Original is calling on Texas\u2019 legislature to add chronic pain as a qualifying condition to the state\u2019s Compassionate Use Program (CUP). The CUP\u2019s current list of qualifying conditions includes ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/texas-original-advocates-to-expand-compassionate-use-program-to-include-chronic-pain\/","og_site_name":"Pharma Trend","article_published_time":"2022-08-31T14:02:10+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220831005134\/en\/1306679\/21\/Texas_Original_Logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/texas-original-advocates-to-expand-compassionate-use-program-to-include-chronic-pain\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/texas-original-advocates-to-expand-compassionate-use-program-to-include-chronic-pain\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Texas Original Advocates To Expand Compassionate Use Program To Include Chronic Pain","datePublished":"2022-08-31T14:02:10+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/texas-original-advocates-to-expand-compassionate-use-program-to-include-chronic-pain\/"},"wordCount":726,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/texas-original-advocates-to-expand-compassionate-use-program-to-include-chronic-pain\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220831005134\/en\/1306679\/21\/Texas_Original_Logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/texas-original-advocates-to-expand-compassionate-use-program-to-include-chronic-pain\/","url":"https:\/\/pharma-trend.com\/en\/texas-original-advocates-to-expand-compassionate-use-program-to-include-chronic-pain\/","name":"Texas Original Advocates To Expand Compassionate Use Program To Include Chronic Pain - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/texas-original-advocates-to-expand-compassionate-use-program-to-include-chronic-pain\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/texas-original-advocates-to-expand-compassionate-use-program-to-include-chronic-pain\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220831005134\/en\/1306679\/21\/Texas_Original_Logo.jpg","datePublished":"2022-08-31T14:02:10+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/texas-original-advocates-to-expand-compassionate-use-program-to-include-chronic-pain\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/texas-original-advocates-to-expand-compassionate-use-program-to-include-chronic-pain\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/texas-original-advocates-to-expand-compassionate-use-program-to-include-chronic-pain\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220831005134\/en\/1306679\/21\/Texas_Original_Logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220831005134\/en\/1306679\/21\/Texas_Original_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/texas-original-advocates-to-expand-compassionate-use-program-to-include-chronic-pain\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Texas Original Advocates To Expand Compassionate Use Program To Include Chronic Pain"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/47855","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=47855"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/47855\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=47855"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=47855"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=47855"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}